Printer Friendly
The Free Library
14,678,552 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Astro-Med Estimates a Profit for the Fourth Quarter Before Restructuring and Other Non-Cash Charges.


Business Editors/High-Tech Writers

WEST WARWICK, R.I.--(BUSINESS WIRE)--Feb. 5, 2003

Astro-Med, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:ALOT ALOT Allotment
ALOT Adaptive Large Optics Technologies
ALOT Airborne Lightweight Optical Tracking
ALOT Maybe you're looking for the two word phrase 'a lot' meaning many?
) announced today it expects to report sales of approximately $13.0 million for the 4th Quarter ended January 31, 2003.

The Company anticipates reporting a profit for the Quarter before a restructuring charge restructuring charge

The expense of reorganizing a company's operations. A restructuring charge is an infrequent expense that generally results from asset writedowns or facility closings.
 of approximately $400,000 and a one-time non-cash charge Non-Cash Charge

A charge off, made by a company against earnings, that does not require an initial outlay of cash.

Notes:
Non-cash charges are typically against the depreciation, amortization, and depletion accounts on a company's balance sheet.
 to the valuation allowance for its deferred tax asset of approximately $1,200,000.

The restructuring charge represents the termination costs associated with a workforce reduction of 8% implemented in January. This personnel reduction is expected to result in annualized annualized

Of or relating to a variable that has been mathematically converted to a yearly rate. Inflation and interest rates are generally annualized since it is on this basis that these two variables are ordinarily stated and compared.
 savings of approximately $2.0 million.

Astro-Med reported sales of $12.4 million and earnings of $41,000 for the corresponding 4th Quarter of the prior year.

The Company's actual results for the 4th Quarter and Fiscal Year will be released on Tuesday, March 25, 2003 and management will discuss the results in detail during its conference call on that day at 11:00 AM EST EST electroshock therapy.

EST
abbr.
electroshock therapy
. The conference call will be broadcast in real time over the Internet. Access is available through the Company's Website at www.astromed.com.

Astro-Med, Inc. is a leading manufacturer of high tech specialty printing systems, electronic medical instrumentation, and test and measurement instruments employed around the world in a wide range of industrial, scientific and medical applications.

Safe Harbor Statement

This news release contains forward-looking statements, and actual results may vary from those expressed or implied herein. Factors that could affect these results include those mentioned in Astro-Med's FY2002 annual report and its annual and quarterly filings with the Securities and Exchange Commission.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 5, 2003
Words:268
Previous Article:Snow's Coming, Don't Forget to Protect Your Eyes According to the Minnesota Optometric Association.
Next Article:Shareholder.com Appoints Michael Detwiler to Senior Vice President.
Topics:



Related Articles
Astro-Med Expects Lower Results For The Third Quarter.
Astro-Med Reports Third Quarter Results; Directors Declare Regular Cash Dividend.
Astro-Med Forecasts Strong Fourth Quarter; Announces Strategic Alliance.
Astro-Med Reports Second Quarter Results; Directors Declare Regular Cash Dividend.
Astro-Med Reports First Quarter Results; Directors Declare Regular Cash Dividend.
Astro-Med Reports Fourth Quarter and Fiscal 2003 Results; Directors Declare Regular Cash Dividend.
Astro-Med Estimates Strong Sales and Profit for the First Quarter.
Astro-Med Reports Strong Second Quarter on Record Sales; Directors Declare Regular Cash Dividend.
Astro-Med Reports Strong Third Quarter on Record Sales; Directors Declare Regular Cash Dividend.
Astro-Med Reports Preliminary Results for Third Quarter.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles